Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

Capell HA, Porter DR, Madhok R, Hunter JA.

Ann Rheum Dis. 1993 Jun;52(6):423-8.

PMID:
8100702
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.

Porter D, Madhok R, Hunter JA, Capell HA.

Ann Rheum Dis. 1992 Apr;51(4):461-4.

PMID:
1350192
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.

Jessop JD, O'Sullivan MM, Lewis PA, Williams LA, Camilleri JP, Plant MJ, Coles EC.

Br J Rheumatol. 1998 Sep;37(9):992-1002.

PMID:
9783766
[PubMed - indexed for MEDLINE]
Free Article
5.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
[PubMed - indexed for MEDLINE]
Free Article
6.

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

Situnayake RD, Grindulis KA, McConkey B.

Ann Rheum Dis. 1987 Mar;46(3):177-83.

PMID:
2883939
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.

Felson DT, Anderson JJ, Meenan RF.

Arthritis Rheum. 1990 Oct;33(10):1449-61.

PMID:
1977391
[PubMed - indexed for MEDLINE]
8.

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V.

Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1099-102.

PMID:
6138116
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

van Jaarsveld CH, Jacobs JW, van der Veen MJ, Blaauw AA, Kruize AA, Hofman DM, Brus HL, van Albada-Kuipers GA, Heurkens AH, ter Borg EJ, Haanen HC, van Booma-Frankfort C, Schenk Y, Bijlsma JW.

Ann Rheum Dis. 2000 Jun;59(6):468-77.

PMID:
10834865
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.

De La Mata J, Blanco FJ, Gómez-Reino JJ.

Ann Rheum Dis. 1995 Nov;54(11):881-5.

PMID:
7492236
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Outcome of second line therapy in rheumatoid arthritis.

Porter DR, McInnes I, Hunter J, Capell HA.

Ann Rheum Dis. 1994 Dec;53(12):812-5.

PMID:
7864689
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.

Grindulis KA, McConkey B.

Ann Rheum Dis. 1984 Jun;43(3):398-401.

PMID:
6146295
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.

Grindulis KA, Scott DL, Robinson MW, Bacon PA, McConkey B.

Br J Rheumatol. 1985 May;24(2):158-63.

PMID:
2859902
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of auranofin in patients with active early rheumatoid arthritis.

Itokazu M, Matsunaga T, Oshita Y.

Clin Ther. 1995 Jan-Feb;17(1):60-73.

PMID:
7758062
[PubMed - indexed for MEDLINE]
15.

The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.

Farr M, Tunn E, Crockson AP, Bacon PA.

Clin Rheumatol. 1984 Dec;3(4):473-81.

PMID:
6151882
[PubMed - indexed for MEDLINE]
16.

Microalbuminuria in patients with rheumatoid arthritis.

Pedersen LM, Nordin H, Svensson B, Bliddal H.

Ann Rheum Dis. 1995 Mar;54(3):189-92.

PMID:
7748016
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.

Galindo-Rodriguez G, Avina-Zubieta JA, Fitzgerald A, LeClerq SA, Russell AS, Suarez-Almazor ME.

J Rheumatol. 1997 Apr;24(4):633-8.

PMID:
9101493
[PubMed - indexed for MEDLINE]
18.

The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.

Forster PJ, McConkey B.

Q J Med. 1986 Jan;58(225):29-42.

PMID:
2871585
[PubMed - indexed for MEDLINE]
19.

Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.

Capell HA, Marabani M, Madhok R, Torley H, Hunter JA.

Q J Med. 1990 Apr;75(276):335-44.

PMID:
1974723
[PubMed - indexed for MEDLINE]
20.

Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Crilly A, Madhok R, Watson J, Capell HA.

Ann Rheum Dis. 1993 Jan;52(1):58-60.

PMID:
8093995
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk